Delivery Order SPE2DB20D3103-SPE2DB24FM4A2
Award Date 1/24/24
Potential Completion Date 1/25/24
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award has a ceiling value of $3,954.80 and a completion date of August 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The contract has a total ceiling value of $10,948.32 and runs through January 31, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,341.22, is for the delivery of Entecavir 0.5 mg tablets. It is a firm fixed-price contract with a period of performance through May 21, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, with a ceiling value of $4,853.55 and a performance period through May 2025. The contract is a firm fixed-price type, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The order has a ceiling value of $6,918.52 and a completion date of August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,955.08 contract is for the supply of Entecavir 0.5mg tablets. It is a firm-fixed-price contract with a period of performance through February 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,434.01 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of October 16, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,483.84, is for the delivery of the pharmaceutical product Entecavir 0.5 mg Tablet 30s. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,015.95 Firm Fixed Price Delivery Order is for the supply of Entecavir 0.5 mg Tablet 30s, a medication used to treat hepatitis B. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. There was no set-aside designation for this open competition contract. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,179.16, is for the delivery of Entecavir 0.5 mg tablets, a prescription medication. The contract has a completion date of August 10, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...